| 摘要 |
The invention relates generally to novel pharmaceutical methods for the t reatment of various conditions. Compositions comprising: at least one phosph odiesterase-5-inhibitor in combination with one or more of the following med ications: a selective serotonin reuptake inhibitor; a serotonin-norepinephri ne reuptake inhibitor; a cholinesterase inhibitor; a dopamine agonist; or a medication suitable to increase the chemical concentrations of the neurotran smitters, selected from amino acids, monoamines, neuropeptides and other age nts capable of primary neurotransmission in the synaptic clefts, and their u se for treating a neurodegenerative disease in a subject. The invention also relates to: Compositions comprising: at least one phosphodiestersa-5-inhibi tor in combination with one or more of the following medications: a selectiv e serotonin reuptake inhibitor; or a cholinesterase inhibitor, and their use for treating damaged skin in a subject.
|
